Christoph H. Westphal, President and CEO at Flex Pharma, Inc. (FLKS), bought 99,126 shares at $10.55 ($1.1M) on 2016-03-24, disclosed to the SEC on 2016-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.55 | 25,356 | $293K | 26.7% |
| 2 | $11.55 | 25,356 | $293K | 26.7% |
| 3 | $10.55 | 24,207 | $255K | 23.3% |
| 4 | $10.55 | 24,207 | $255K | 23.3% |
| Total | $11.06 avg | 99,126 | $1.1M | 100% |
| Filing → |
| FLKS | BUY | 2016-11-08 | $51K | — | Filing → |
| FLKS | BUY | 2016-11-07 | $51K | — | Filing → |
| FLKS | BUY | 2016-06-24 | $30K | — | Filing → |